Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Caldivirga maquilingensis Prefoldin subunit beta (pfdB) CSB-YP428820CVY
CSB-EP428820CVY
CSB-BP428820CVY
CSB-MP428820CVY
CSB-EP428820CVY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caldivirga maquilingensis Glycerol-1-phosphate dehydrogenase [NAD (P)+] CSB-YP428821CVY
CSB-EP428821CVY
CSB-BP428821CVY
CSB-MP428821CVY
CSB-EP428821CVY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caldivirga maquilingensis Probable tRNA threonylcarbamoyladenosine biosynthesis protein KAE1 homolog (Cmaq_0593) CSB-YP428822CVY
CSB-EP428822CVY
CSB-BP428822CVY
CSB-MP428822CVY
CSB-EP428822CVY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caldivirga maquilingensis Phosphoribosylformylglycinamidine synthase 2 (purL), partial CSB-YP428823CVY
CSB-EP428823CVY
CSB-BP428823CVY
CSB-MP428823CVY
CSB-EP428823CVY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caldivirga maquilingensis Geranylgeranylglyceryl phosphate synthase (Cmaq_0928) CSB-YP428824CVY
CSB-EP428824CVY
CSB-BP428824CVY
CSB-MP428824CVY
CSB-EP428824CVY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caldivirga maquilingensis Anthranilate phosphoribosyltransferase (trpD) CSB-YP428825CVY
CSB-EP428825CVY
CSB-BP428825CVY
CSB-MP428825CVY
CSB-EP428825CVY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caldivirga maquilingensis Ketol-acid reductoisomerase (ilvC) CSB-YP428826CVY
CSB-EP428826CVY
CSB-BP428826CVY
CSB-MP428826CVY
CSB-EP428826CVY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus oremlandii DNA replication and repair protein recF (recF) CSB-YP428827AUQ
CSB-EP428827AUQ
CSB-BP428827AUQ
CSB-MP428827AUQ
CSB-EP428827AUQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus oremlandii Dihydrodipicolinate synthase (dapA) CSB-YP428828AUQ
CSB-EP428828AUQ
CSB-BP428828AUQ
CSB-MP428828AUQ
CSB-EP428828AUQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus oremlandii Glutamate 5-kinase (proB) CSB-YP428829AUQ
CSB-EP428829AUQ
CSB-BP428829AUQ
CSB-MP428829AUQ
CSB-EP428829AUQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus oremlandii Glycerol kinase (glpK), partial CSB-YP428830AUQ
CSB-EP428830AUQ
CSB-BP428830AUQ
CSB-MP428830AUQ
CSB-EP428830AUQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus oremlandii Putative phosphotransferase Clos_1257 (Clos_1257) CSB-YP428831AUQ
CSB-EP428831AUQ
CSB-BP428831AUQ
CSB-MP428831AUQ
CSB-EP428831AUQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus oremlandii Alanine--tRNA ligase (alaS), partial CSB-YP428832AUQ
CSB-EP428832AUQ
CSB-BP428832AUQ
CSB-MP428832AUQ
CSB-EP428832AUQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus oremlandii Protein MraZ (mraZ) CSB-YP428833AUQ
CSB-EP428833AUQ
CSB-BP428833AUQ
CSB-MP428833AUQ
CSB-EP428833AUQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus oremlandii GTPase Der (der) CSB-YP428834AUQ
CSB-EP428834AUQ
CSB-BP428834AUQ
CSB-MP428834AUQ
CSB-EP428834AUQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus oremlandii Ribosomal RNA large subunit methyltransferase N (rlmN) CSB-YP428835AUQ
CSB-EP428835AUQ
CSB-BP428835AUQ
CSB-MP428835AUQ
CSB-EP428835AUQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus oremlandii 30S ribosomal protein S2 (rpsB) CSB-YP428836AUQ
CSB-EP428836AUQ
CSB-BP428836AUQ
CSB-MP428836AUQ
CSB-EP428836AUQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus oremlandii 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr) CSB-YP428837AUQ
CSB-EP428837AUQ
CSB-BP428837AUQ
CSB-MP428837AUQ
CSB-EP428837AUQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus oremlandii Selenide, water dikinase (selD) CSB-YP428838AUQ
CSB-EP428838AUQ
CSB-BP428838AUQ
CSB-MP428838AUQ
CSB-EP428838AUQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus oremlandii Probable tRNA sulfurtransferase (thiI) CSB-YP428839AUQ
CSB-EP428839AUQ
CSB-BP428839AUQ
CSB-MP428839AUQ
CSB-EP428839AUQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>